Total Payments
$37,153
2024 Payments
$3,981
Companies
68
Transactions
1,834
Medicare Patients
960
Medicare Billing
$121,643
Payment Breakdown by Category
Food & Beverage$23,596 (63.5%)
Travel$7,125 (19.2%)
Other$4,250 (11.4%)
Research$2,101 (5.7%)
Education$61.38 (0.2%)
Gifts$20.00 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $23,596 | 1,788 | 63.5% |
| Travel and Lodging | $7,125 | 27 | 19.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,250 | 1 | 11.4% |
| Unspecified | $2,101 | 11 | 5.7% |
| Education | $61.38 | 6 | 0.2% |
| Gift | $20.00 | 1 | 0.1% |
Payments by Type
General
$35,052
1,823 transactions
Research
$2,101
11 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $6,524 | 558 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $5,169 | 257 | $0 (2024) |
| Life Technologies Corporation | $4,250 | 1 | $0 (2021) |
| GlaxoSmithKline, LLC. | $4,150 | 154 | $0 (2024) |
| Merck Sharp & Dohme LLC | $1,714 | 68 | $0 (2023) |
| Novo Nordisk AS | $1,689 | 6 | $0 (2018) |
| ABBVIE INC. | $1,355 | 97 | $0 (2024) |
| SANOFI PASTEUR INC. | $1,355 | 7 | $0 (2024) |
| Seqirus USA Inc | $1,176 | 4 | $0 (2019) |
| Amgen Inc. | $708.53 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,981 | 132 | SANOFI PASTEUR INC. ($1,355) |
| 2023 | $2,372 | 148 | AstraZeneca Pharmaceuticals LP ($544.71) |
| 2022 | $2,450 | 141 | AstraZeneca UK Limited ($470.07) |
| 2021 | $6,470 | 150 | Life Technologies Corporation ($4,250) |
| 2020 | $2,357 | 128 | PFIZER INC. ($605.14) |
| 2019 | $9,126 | 376 | PFIZER INC. ($2,619) |
| 2018 | $6,721 | 390 | Novo Nordisk AS ($1,689) |
| 2017 | $3,675 | 369 | PFIZER INC. ($815.24) |
All Payment Transactions
1,834 individual payment records from CMS Open Payments — Page 1 of 74
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $17.19 | General |
| 12/17/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $42.50 | General |
| Category: Endocrinology | ||||||
| 12/16/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: Oncology | ||||||
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: Respiratory | ||||||
| 12/09/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: Respiratory | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: Respiratory | ||||||
| 11/12/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $36.67 | General |
| Category: Endocrinology | ||||||
| 11/07/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $26.53 | General |
| Category: Biological | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: Respiratory | ||||||
| 11/01/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: Diabetes Care | ||||||
| 10/31/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: Diabetes | ||||||
| 10/30/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: Hematology | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: Respiratory | ||||||
| 10/27/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: Oncology | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Respiratory | ||||||
| 10/21/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $21.94 | General |
| Category: Respiratory | ||||||
| 10/18/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.51 | General |
| Category: Biological | ||||||
| 10/08/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: PAIN | ||||||
| 10/03/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: Biological | ||||||
| 10/03/2024 | Amphastar Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $14.25 | General |
| 10/02/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: Obesity | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: Respiratory | ||||||
| 09/19/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: NEUROSCIENCE | ||||||
| 09/18/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Respiratory | ||||||
| 09/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: Respiratory | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Phase III, Randomized, Single-blind, Placebo-controlled, Multi-center Study to Evaluate Non-interference of Concomitant Administration of Routine Pediatric Vaccines on the Antibody Response of an Investigational Live-attenuated Respiratory Syncytial Virus (RSV) Vaccine in Healthy Infants and Toddlers (CORAL) | SANOFI PASTEUR INC. | $1,355 | 7 |
| BREXPIPRAZOLE AS COMBINATION THERAPY WITH SERTRALINE IN TREATMENT OF ADULTS WITH PTSD | Otsuka Pharmaceutical Development & Commercialization, Inc. | $521.26 | 3 |
| A MULTICENTER, OPEN-LABEL STUDY TO EVALUATE THE SAFETY AND TOBERABILITY OF METRONIDAZOLE VAGINAL GEN 1.3 IN ADOLESCENT FEMALE SUBJECTS WITH BACTERIAL VAGINOSIS | Allergan Inc. | $225.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 220 | 530 | $75,371 | $26,328 |
| 2022 | 5 | 248 | 535 | $73,720 | $29,494 |
| 2021 | 5 | 237 | 576 | $77,023 | $36,608 |
| 2020 | 5 | 255 | 589 | $75,340 | $29,214 |
Total Patients
960
Total Services
2,230
Medicare Billing
$121,643
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 81 | 311 | $47,800 | $16,193 | 33.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 40 | 84 | $17,910 | $6,824 | 38.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 22 | 22 | $4,400 | $2,695 | 61.3% |
| 99422 | Online digital evaluation and management service for an established patient for up to 7 days, total time 11-20 minutes | Office | 2023 | 16 | 17 | $2,205 | $217.40 | 9.9% |
| 82947 | Blood glucose (sugar) level | Office | 2023 | 23 | 42 | $1,050 | $161.70 | 15.4% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 12 | 16 | $1,056 | $152.32 | 14.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 26 | 38 | $950.00 | $83.60 | 8.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 93 | 311 | $42,135 | $16,047 | 38.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 52 | 102 | $18,360 | $8,038 | 43.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 37 | 37 | $7,400 | $4,659 | 63.0% |
| 99422 | Online digital evaluation and management service for an established patient for up to 7 days, total time 11-20 minutes | Office | 2022 | 26 | 37 | $4,625 | $643.25 | 13.9% |
| 81003 | Automated urinalysis test | Office | 2022 | 40 | 48 | $1,200 | $106.55 | 8.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 99 | 366 | $45,773 | $20,819 | 45.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 72 | 138 | $23,460 | $11,813 | 50.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 25 | 25 | $5,000 | $3,217 | 64.3% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 18 | 19 | $2,090 | $696.00 | 33.3% |
| 81003 | Automated urinalysis test | Office | 2021 | 23 | 28 | $700.00 | $63.00 | 9.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 76 | 213 | $36,210 | $15,120 | 41.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 103 | 270 | $33,855 | $12,124 | 35.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 15 | 15 | $3,000 | $1,679 | 56.0% |
| 82947 | Blood glucose (sugar) level | Office | 2020 | 32 | 53 | $1,325 | $206.53 | 15.6% |
| 81003 | Automated urinalysis test | Office | 2020 | 29 | 38 | $950.00 | $84.90 | 8.9% |
About Dr. Martin Schear, MD
Dr. Martin Schear, MD is a Family Medicine healthcare provider based in Dayton, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/18/2005. The National Provider Identifier (NPI) number assigned to this provider is 1801885355.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Martin Schear, MD has received a total of $37,153 in payments from pharmaceutical and medical device companies, with $3,981 received in 2024. These payments were reported across 1,834 transactions from 68 companies. The most common payment nature is "Food and Beverage" ($23,596).
As a Medicare-enrolled provider, Schear has provided services to 960 Medicare beneficiaries, totaling 2,230 services with total Medicare billing of $121,643. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Dayton, OH
- Active Since 10/18/2005
- Last Updated 10/27/2011
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1801885355
Products in Payments
- CHANTIX (Drug) $2,056
- FARXIGA (Drug) $1,794
- BREZTRI (Drug) $1,624
- FLUCELVAX QUADRIVALENT (MULTI-DOSE VIAL) (Biological) $1,176
- V114 (Biological) $1,154
- VRAYLAR (Drug) $865.28
- BEVESPI AEROSPHERE (Drug) $800.85
- ELIQUIS (Drug) $768.04
- LYRICA (Drug) $605.12
- PREVNAR - 13 (Biological) $581.22
- Repatha (Biological) $577.56
- REXULTI (Drug) $571.26
- Kerendia (Drug) $523.44
- Vascepa (Drug) $512.53
- QULIPTA (Drug) $451.19
- NURTEC ODT (Drug) $433.96
- ENTRESTO (Drug) $386.77
- JANUVIA (Drug) $380.52
- XARELTO (Drug) $356.68
- XIFAXAN (Drug) $323.47
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Dayton
Steve Choi, M.d, M.D
Family Medicine — Payments: $364,881
Family Medicine $364,881
Dr. Kimbra Joyce, Do, DO
Family Medicine — Payments: $19,274
Family Medicine $19,274
Dr. Kwasi Nenonene, M.d, M.D
Family Medicine — Payments: $16,548
Family Medicine $16,548
Dr. Clem Kirkland, M.d, M.D
Family Medicine — Payments: $15,511
Family Medicine $15,511
Dr. Jeanne Kirkland, M.d, M.D
Family Medicine — Payments: $15,417
Family Medicine $15,417
Dr. Barbara Bennett, D.o, D.O
Family Medicine — Payments: $15,125
Family Medicine $15,125